|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/30 | |||
| C07K 14/47 | |||
| A61P 35/00 |
| (11) | Number of the document | 3095797 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16164567.6 |
| Date of filing the European patent application | 2013-02-22 | |
| (97) | Date of publication of the European application | 2016-11-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261603173 P | 2012-02-24 | US | |
| 201261719803 P | 2012-10-29 | US |
| (72) |
STULL, Robert, A., US
SAUNDERS, Laura, US
DYLLA, Scott, J., US
FOORD, Orit, US
LIU, David, US
TORGOV, Michael, US
SHAO, Hui, US
|
| (73) |
AbbVie Stemcentrx LLC,
1 North Waukegan Road, North Chicago, IL 60064-6400,
US
|
| (54) | ANTI DLL3 ANTIBODIES AND METHODS OF USE THEREOF |
| ANTI DLL3 ANTIBODIES AND METHODS OF USE THEREOF |